Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 17 Oct 2025 for Aquestive Therapeutics, Inc., €122k. Read the official filing
Filing timeline
BuySaleCarl N. Kraus
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Carl N. Kraus: trading record in brief
This profile gathers the share dealings of Carl N. Kraus in Aquestive Therapeutics, Inc., where the filings describe the role as senior executive. The record holds 6 filings, for trades running from 9 August 2023 to 15 October 2025.
On the market, this insider has only sold: 1 sale, €122k in total. Outside the open market, there are 5 share grants. In 2025 alone, the filings show no purchases and 1 sale.
The latest filing, published on 17 October 2025, reports an open-market sale of €122k in Aquestive Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Carl N. Kraus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
20,272 shares@ US$7.000.015% mcap50.0% of flowCommon StockSEC:0001214659-25-015047:0
10,819 shares@ US$3.9011.5% of flowCommon StockSEC:0001214659-25-011823:0
70,000 shares0Common StockSEC:0001214659-25-004225:0
10,819 shares@ US$3.4310.8% of flowCommon StockSEC:0001214659-24-014226:0
112,500 shares0Common StockSEC:0001214659-24-004306:0
150,000 shares0Common StockSEC:0001214659-23-010919:0
6 of 6 declarations
